MEITAV INVESTMENT HOUSE LTD - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is NTEC and the CUSIP is M53644148. A total of 20 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2021$840,000
+58.8%
241,982
+100.0%
0.01%
-26.7%
Q1 2021$529,000
+26.9%
120,991
+0.1%
0.02%
-6.2%
Q4 2020$417,000120,8160.02%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q4 2020
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 82,761$286,0000.07%
Virtu Financial LLC 66,497$229,0000.02%
MEITAV INVESTMENT HOUSE LTD 120,816$417,0000.02%
GSA CAPITAL PARTNERS LLP 15,306$53,0000.01%
HighPoint Advisor Group LLC 10,000$59,0000.01%
SABBY MANAGEMENT, LLC 10,199$35,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 961$3,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 15,089$52,0000.00%
MILLENNIUM MANAGEMENT LLC 46,934$162,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders